Company intelligence / Profile preview

Omini

Perth, Western Australia, Australiaomini.ai ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Australian 'Omni Biotech': Completed $300k pre-seed round in December 2023 to develop world-first real-time hydration monitoring using existing wearable/smartphone sensors. Validation study ongoing at Monash University. No clinical drug results as it is a digital health/device play. US 'Omni Bio Pharmaceutical': Developing new uses for plasma-derived/recombinant alpha‑1 antitrypsin with focus on immune-mediated inflammatory diseases. No recent published clinical trial results found; programs appear early-stage or preclinical.

Therapeutic areas
EndocrinologyImmunologyOtherGastroenterologyCardiovascularNephrologyInfectious Diseases
Modalities
DeviceDigital health algorithmProtein therapyRecombinant protein
Industry
Biotech
02

Partnerships

Skalata Ventures investmentvalidation study at Monash UniversityCollaborations with AAT manufacturers and academic research groups mentioned generally

Beyond the preview

Go deeper on Omini.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omini.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call